Psychedelic Therapeutics & Drug Development Conference
May 23 – 24, 2024 // Boston, MA
Join Worldwide Clinical Trials at the Psychedelic Therapeutics & Drug Development Conference.
0
days leftAbout event
This event brings together the world’s leading researchers and leaders in academia, industry, the non-profit sector and government to discuss the challenges and opportunities facing those engaged in the research and development of psychedelics for various health conditions with considerable unmet need. If you are attending the Psychedelic Therapeutics & Drug Development Conference stop and say hello to our team.
Don’t miss Christine Moore’s presentation, Designing a Psychedelic Clinical Trial for Borderline Personality Disorder, on Thursday May 23 at 11:05 A.M EST.
Julia Forte, Senior Director, Project Management, will be participating in panel Optimizing Psychedelic Trials; Therapy, Monitoring and Artificial Intelligence on May 23 at 8:10 A.M EST.
Date
Thursday to Friday
May 23-24, 2024
Venue
Revere Hotel Boston Commons
200 Stuart St.
Boston, MA 02116
Christine Moore, PhD
Vice President, Neuroscience, Scientific Solutions
Christine K. Moore, PhD, Vice President, Neuroscience, Scientific Solutions provides strategic scientific guidance across multiple programs, driving neuroscience clinical research of the highest quality for the company. With over 25 years of drug development and commercialization experience, Dr. Moore’s experience extends from scientific to operational expertise across neuroscience indications. As one of the original team members at Worldwide Clinical Trials, she has held diverse roles within CROs as well as with large and small pharma. Her unique and broad industry experience allows for planning clinical trials that are both methodologically rigorous and feasible, and that will ultimately enable commercial product adoption by payers and health care providers after approval.
